tenalif multi symptom relief

Generic: acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl

Labeler: opmx llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name tenalif multi symptom relief
Generic Name acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl
Labeler opmx llc
Dosage Form SYRUP
Routes
ORAL
Active Ingredients

acetaminophen 500 mg/20mL, dextromethorphan hydrobromide 26.66 mg/20mL, guaifenesin 400 mg/20mL, phenylephrine hydrochloride 10 mg/20mL

Manufacturer
OPMX LLC

Identifiers & Regulatory

Product NDC 69729-051
Product ID 69729-051_2860d795-bd63-8835-e063-6394a90ac28f
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2023-09-18

Pharmacologic Class

Established (EPC)
expectorant [epc]
Physiologic Effect
decreased respiratory secretion viscosity [pe] increased respiratory secretions [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69729051
Hyphenated Format 69729-051

Supplemental Identifiers

RxCUI
1790651
UPC
0856828008915
UNII
362O9ITL9D 9D2RTI9KYH 495W7451VQ 04JA59TNSJ
NUI
N0000193956 N0000008867 N0000009560

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tenalif multi symptom relief (source: ndc)
Generic Name acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/20mL
  • 26.66 mg/20mL
  • 400 mg/20mL
  • 10 mg/20mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (69729-051-06) / 177 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

69729-051-06 1 BOTTLE, PLASTIC in 1 CARTON (69729-051-06) / 177 mL in 1 BOTTLE, PLASTIC

Ingredients (4)

acetaminophen (500 mg/20mL) dextromethorphan hydrobromide (26.66 mg/20mL) guaifenesin (400 mg/20mL) phenylephrine hydrochloride (10 mg/20mL)

Linked Drug Pages (1)

Tenalif Multi Symptom Relief ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2860d795-bd63-8835-e063-6394a90ac28f", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0856828008915"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1790651"], "spl_set_id": ["05cd94e7-1808-3bb3-e063-6294a90a4140"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["OPMX LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (69729-051-06)  / 177 mL in 1 BOTTLE, PLASTIC", "package_ndc": "69729-051-06", "marketing_start_date": "20230918"}], "brand_name": "Tenalif Multi Symptom Relief", "product_id": "69729-051_2860d795-bd63-8835-e063-6394a90ac28f", "dosage_form": "SYRUP", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "69729-051", "generic_name": "Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl", "labeler_name": "OPMX LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Tenalif Multi Symptom Relief", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "500 mg/20mL"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "26.66 mg/20mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/20mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/20mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230918", "listing_expiration_date": "20261231"}